Similar articles

• Current indications for ACE inhibitors and HOPE for the future.

  Burch S, Ou N. Burch S, et al. Am J Manag Care. 2002 May;8(5):478-90; quiz 491-3. Am J Manag Care. 2002. PMID: 12019599 Review.
• ACE inhibitors in high risk cardiovascular patients: a new hope from the HOPE study.

  Gambhir DS. Gambhir DS. Indian Heart J. 2000 Mar-Apr;52(2):127-8, 211. Indian Heart J. 2000. PMID: 10893889 No abstract available.
• [ACE inhibitor or AT1 antagonist. Is there a differential therapy?].

  Unger T, Rangoonwala B, Rosenthal J. Unger T, et al. MMW Fortschr Med. 2002 Jun 13;144(24):36-8. MMW Fortschr Med. 2002. PMID: 12134723 German.
• Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology.

  López-Sendón J, Swedberg K, McMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C; Task Force on ACE-inhibitors of the European Society of Cardiology. López-Sendón J, et al. Eur Heart J. 2004 Aug;25(16):1454-70. doi: 10.1016/j.ehj.2004.06.003. Eur Heart J. 2004. PMID: 15302105 Review. No abstract available.
• [Angiotensin receptor blocker often a valuable alternative to ACE inhibitors].

  Partanen J. Partanen J. Duodecim. 2003;119(13):1193-6. Duodecim. 2003. PMID: 12908180 Finnish. No abstract available.